Paratek Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $127.74 Millions, with shareholders equity totaling $-201.37 Millions.
The company employs approximately 197 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Paratek Pharmaceuticals Inc. reported $203.73 Millions in revenue, generating net income of $-62.73 Millions.
Key financial metrics include a P/E ratio of -2.04, a price-to-book (P/B) ratio of -0.63, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PRTK.